Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

126 results about "Silica matrix" patented technology

Multimodal silica-based nanoparticles

The present invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring and treatment of a disease such as cancer. The nanoparticle has a range of diameters including between about 0.1 nm and about 100 nm, between about 0.5 nm and about 50 nm, between about 1 nm and about 25 nm, between about 1 nm and about 15 nm, or between about 1 nm and about 8 nm. The nanoparticle has a fluorescent compound positioned within the nanoparticle, and has greater brightness and fluorescent quantum yield than the free fluorescent compound. The nanoparticle also exhibits high biostability and biocompatibility. To facilitate efficient urinary excretion of the nanoparticle, it may be coated with an organic polymer, such as poly(ethylene glycol) (PEG). The small size of the nanoparticle, the silica base and the organic polymer coating minimizes the toxicity of the nanoparticle when administered in vivo. In order to target a specific cell type, the nanoparticle may further be conjugated to a ligand, which is capable of binding to a cellular component associated with the specific cell type, such as a tumor marker. In one embodiment, a therapeutic agent may be attached to the nanoparticle. To permit the nanoparticle to be detectable by not only optical fluorescence imaging, but also other imaging techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), computerized tomography (CT), bioluminescence imaging, and magnetic resonance imaging (MRI), radionuclides/radiometals or paramagnetic ions may be conjugated to the nanoparticle.
Owner:SLOAN KETTERING INST FOR CANCER RES +1

Selective separation of PCNs (polychlorinated naphthalenes congeners), HBCDss (hexabromocyclododecanes) and TBBPA (tetrabromobisphenol A) in complex samples

The invention relates to utilization of a silica matrix as a sample pretreatment material, wherein a) PCNs (polychlorinated naphthalenes congeners), HBCDs (hexabromocyclododecanes) and TBBPA (tetrabromobisphenol A) in complex samples are extracted by a solvent extraction method and an extract containing target analytes is obtained; b) the silica matrix is selected as a chromatographic column filler; the filer is activated by using normal hexane at first and then the extract is loaded; c) the polychlorinated naphthalenes congeners, hexabromocyclododecanes and tetrabromobisphenol A are eluted orderly by using organic solvents (normal hexane, dichloromethane and the like) composed of different solvents, and then three eluates of different fractions are obtained; d) after solvents are volatilized from the eluates, the purified target analytes are obtained. According to the invention, selective separation of the polychlorinated naphthalenes congeners, hexabromocyclododecanes and tetrabromobisphenol A in the complex samples is realized by virtue of a simple chromatographic column; the method has the advantages of simplicity in operation, good selectivity and high efficiency.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Polysaccharide extraction method based on epoxy magnetic microspheres

The invention relates to the technical field of separation of biological active substances and provides a preparation method of magnetic microspheres and a method for extracting water-soluble polysaccharides from a waterborne matrix by virtue of the microspheres. The method comprises the following steps: firstly, mixing citric acid modified magnetic nanoparticles with water glass, ultrasonically dispersing in emulsifier-containing dichloromethane to form water-in-oil emulsion, pouring the emulsion into a buffer solution, and curing the water glass to form magnetic microspheres of a SiO2 matrix; secondly, performing surface modification by using epoxy silane, adding the microspheres into polysaccharide crude extract liquid, adding ethanol with weight being 1-2 times that of the polysaccharide crude extract liquid, enabling polysaccharides to form flocculated precipitates for wrapping the magnetic microspheres, and performing solid-liquid separation by using a magnet. According to the method, the polysaccharide recovery rate is equivalent to that of a conventional centrifugal method but the protein impurity content is remarkably reduced, the process is simplified, the time consumption is only 1/10 that of the conventional method, and the magnetic microspheres can be repeatedly utilized; the method has wide application prospects in the field of biological separation, especially pretreatment of extraction, separation and sample analysis of animals, plants and fungal polysaccharides.
Owner:TAISHAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products